In last trading session, Lyell Immunopharma Inc (NASDAQ:LYEL) saw 1.42 million shares changing hands with its beta currently measuring -0.35. Company’s recent per share price
During the recent session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.63 million, with the beta value of the company hitting -0.36. At the last
In the last trading session, 2.22 million shares of the Lyell Immunopharma Inc (NASDAQ:LYEL) were traded, and its beta was -0.36. Most recently the company’s
In the last trading session, 2.03 million shares of the Lyell Immunopharma Inc (NASDAQ:LYEL) were traded, and its beta was -0.36. Most recently the company’s
Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 0.72 million during the last session, with the company’s beta value hitting -0.36. At the close of
In the last trading session, 1.01 million Lyell Immunopharma Inc (NASDAQ:LYEL) shares changed hands as the company’s beta touched -0.37. With the company’s per share
In last trading session, Lyell Immunopharma Inc (NASDAQ:LYEL) saw 0.87 million shares changing hands with its beta currently measuring -0.36. Company’s recent per share price
During the last session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.79 million, with the beta value of the company hitting -0.37. At the end
Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting -0.36. At the close of
In the latest trading session, 0.43 million Lyell Immunopharma Inc (NASDAQ:LYEL) shares changed hands as the company’s beta touched -0.35. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
